PCR122 Psychometric Evaluation of Multiple Sclerosis Impact Scale 29 Version 2 in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2561
https://www.valueinhealthjournal.com/article/S1098-3015(23)05691-7/fulltext
Title :
PCR122 Psychometric Evaluation of Multiple Sclerosis Impact Scale 29 Version 2 in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05691-7&doi=10.1016/j.jval.2023.09.2561
First page :
Section Title :
Open access? :
No
Section Order :
11902